Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study

Efficacy and Safety of Bicyclol Treatment for Non-Alcoholic Fatty Liver Disease: Results of a Cohort Study

Aim. This study is aimed at evaluating the efficacy and safety of Bicyclol administration in patients suffering from non-alcoholic fatty liver disease (NAFLD) («ZIGUN» research) by monitoring laboratory data and non-invasive methods of diagnosis of liver fibrosis and steatosis.Materials and methods....

Full description

Bibliographic Details
Main Authors:	I. Yu. Pirogova, S. V. Yakovleva, T. V. Neuymina, S. P. Sinitsyn, V. S. Chulkov, T. N. Shamaeva
Format:	Article
Language:	Russian
Published:	Gastro LLC 2018-09-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	nonalcoholic fatty liver disease liver fibrosis liver steatosis bicyclol
Online Access:	https://www.gastro-j.ru/jour/article/view/253

Similar Items

The effect of symbiotic supplementation on liver enzymes, c-reactive protein and ultrasound findings in patients with non-alcoholic fatty liver disease: A clinical trial
by: Atefe Asgharian, et al.
Published: (2016-01-01)

ADEMETHIONINE IN THERAPY OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: A. V. Polukhina, et al.
Published: (2017-11-01)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01)

Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
by: Jennifer Gallacher, et al.
Published: (2018-06-01)

5-Lipooxygenase Derivatives as Serum Biomarkers of a Successful Dietary Intervention in Patients with NonAlcoholic Fatty Liver Disease
by: Marcin Banaszczak, et al.
Published: (2020-02-01)

The Accuracy of Serum Biomarkers in the Diagnosis of Steatosis, Fibrosis, and Inflammation in Patients with Nonalcoholic Fatty Liver Disease in Comparison to a Liver Biopsy
by: Ivana Mikolasevic, et al.
Published: (2022-02-01)

Multinodular fatty liver after herpes-zoster vaccine: Case report and review of the literature
by: Michael Shim, et al.
Published: (2008-10-01)

Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience
by: Xiaoling Chi, et al.
Published: (2019-06-01)

Metabolically associated fatty liver disease – a disease of the 21st century: A review
by: Igor V. Maev, et al.
Published: (2022-07-01)

Resveratrol and liver: A systematic review
by: Forouzan Faghihzadeh, et al.
Published: (2015-01-01)

Treatment Options in Non-alcoholic Fatty Liver Disease
by: Won Kim
Published: (2017-06-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

The role of zinc in the prevention and treatment of nonalcoholic fatty liver disease
by: Mary Barbara, et al.
Published: (2021-09-01)

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease
by: Juan Pablo Arab, et al.
Published: (2020-11-01)

Effect of Bicyclol tablets on drug induced liver injuries after kidney transplantation
by: Shang Wenjun, et al.
Published: (2017-05-01)

Prognostic impact of liver fibrosis and steatosis by transient elastography for cardiovascular and mortality outcomes in individuals with nonalcoholic fatty liver disease and type 2 diabetes: the Rio de Janeiro Cohort Study
by: Claudia R. L. Cardoso, et al.
Published: (2021-09-01)

Comparison of liver enzymes level and sonographic findings value with liver biopsy findings in nonalcoholic fatty liver disease patients
by: Mahsa Khodadoostan, et al.
Published: (2016-01-01)

Oxidative Stress and Pro-Inflammatory Status in Patients with Non-Alcoholic Fatty Liver Disease
by: Margalida Monserrat-Mesquida, et al.
Published: (2020-08-01)

The FINDRISC scale as a risk assessment tool for liver fibrosis in patients with nonalcoholic fatty liver disease
by: A. S. Kuznetsova, et al.
Published: (2023-01-01)

Liver biopsy in the quantitative assessment of liver fibrosis in nonalcoholic fatty liver disease
by: Gwyneth Shook Ting Soon, et al.
Published: (2021-01-01)

Assessment of laboratory findings and liver elastography in patients with non-alcoholic fatty liver disease
by: Tarang Taghvaei, et al.
Published: (2023-12-01)

Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice
by: Bahman Rostama, et al.
Published: (2020-12-01)

Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease—Current Background, Hopes, and Perspectives
by: Georgiana-Diana Cazac, et al.
Published: (2023-04-01)

Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients
by: "Ebrahimi Daryani N, et al.
Published: (2003-03-01)

What are the common downstream molecular events between alcoholic and nonalcoholic fatty liver?
by: Giovanni Tarantino, et al.
Published: (2024-02-01)

Stratification by Non-invasive Biomarkers of Non-alcoholic Fatty Liver Disease in Children
by: Yiyoung Kwon, et al.
Published: (2022-04-01)

Noninvasive diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2017-09-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

CT-based Hounsfield unit values reflect the degree of steatohepatitis in patients with low-grade fatty liver disease
by: Ha Neul Kim, et al.
Published: (2023-03-01)

Clinical and prognostic value of metabolic disorders in non-alcoholic fatty liver disease
by: Ya. M. Vakhrushev, et al.
Published: (2020-12-01)

Blood lead level is associated with advanced liver fibrosis in patients with non-alcoholic fatty liver disease: A nationwide survey (NHANES 2011–2016)
by: Debashis Reja, et al.
Published: (2020-07-01)

CLINICAL AND LABORATORY FEATURES OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: Derbak M. A., et al.
Published: (2020-12-01)

Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
by: Karima Begriche, et al.
Published: (2023-01-01)

Therapeutic Effects of Vitamin E in Non-alcoholic Fatty Liver Disease: An Open-Labeled Clinical Trial
by: Amal jawad Fairooz, et al.
Published: (2022-12-01)

Relationship of sarcopenia with steatohepatitis and advanced liver fibrosis in non-alcoholic fatty liver disease: a meta-analysis
by: Rui Yu, et al.
Published: (2018-04-01)

Nonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosis
by: Rasha AlShaalan, et al.
Published: (2015-01-01)

Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees
by: Kenichiro Murayama, et al.
Published: (2021-01-01)

Honokiol Improves Liver Steatosis in Ovariectomized Mice
by: Yeon-Hui Jeong, et al.
Published: (2018-01-01)

Collagen co-localized with macrovesicular steatosis better differentiates fibrosis progression in non-alcoholic fatty liver disease mouse models
by: Xiao-Xiao Wang, et al.
Published: (2023-06-01)

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
by: Gwyneth Soon, et al.
Published: (2021-01-01)